Skip Nav Destination
Issues
June 2022
-
Cover Image
Cover Image
Cover: Goldfish; photograph of a watercolor painting.
Credit: IlexImage. For more information, please visit istock.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Commentaries
SGLT2i Increase Endogenous Glucose Production: That’s Good News!
Diabetes Care May 2022, Vol.45, 1301-1302. doi:https://doi.org/10.2337/dci22-0010
Carbohydrates, Insulin Secretion, and “Precision Nutrition”
Topics:
carbohydrates
,
diet
,
insulin
,
insulin secretion
,
science of nutrition
Diabetes Care May 2022, Vol.45, 1303-1305. doi:https://doi.org/10.2337/dci22-0009
Clinical Care / Education / Nutrition / Psychosocial Research
Weight Change During the Postintervention Follow-up of Look AHEAD
Rena R. Wing; Rebecca H. Neiberg; Judy L. Bahnson; Jeanne M. Clark; Mark A. Espeland; James O. Hill; Karen C. Johnson; William C. Knowler; KayLoni Olson; Helmut Steinburg; Xavier Pi-Sunyer; Thomas A. Wadden; Holly Wyatt; on behalf of the Look AHEAD Research Group
Topics:
body weight changes
,
follow-up
,
weight reduction
,
frailty
,
depressive disorders
Diabetes Care April 2022, Vol.45, 1306-1314. doi:https://doi.org/10.2337/dc21-1990
Epidemiology / Health Services Research
Associations Between Dietary Patterns and Incident Type 2 Diabetes: Prospective Cohort Study of 120,343 UK Biobank Participants
Min Gao; Susan A. Jebb; Paul Aveyard; Gina L. Ambrosini; Aurora Perez-Cornago; Keren Papier; Jennifer Carter; Carmen Piernas
Topics:
diabetes mellitus, type 2
,
diet
,
biobanks
,
sugars
,
obesity
Diabetes Care March 2022, Vol.45, 1315-1325. doi:https://doi.org/10.2337/dc21-2258
Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults
Sridharan Raghavan; Theodore Warsavage; Wenhui G. Liu; Katherine Raffle; Kevin Josey; David R. Saxon; Lawrence S. Phillips; Liron Caplan; Jane E.B. Reusch
Topics:
diabetes mellitus, type 2
,
follow-up
,
glycemic control
,
hemoglobin a, glycosylated
,
metformin
Diabetes Care March 2022, Vol.45, 1335-1345. doi:https://doi.org/10.2337/dc21-2492
A Machine Learning–Based Predictive Model to Identify Patients Who Failed to Attend a Follow-up Visit for Diabetes Care After Recommendations From a National Screening Program
Akira Okada; Yohei Hashimoto; Tadahiro Goto; Satoko Yamaguchi; Sachiko Ono; Kayo Ikeda Kurakawa; Masaomi Nangaku; Toshimasa Yamauchi; Hideo Yasunaga; Takashi Kadowaki
Topics:
antihypertensive agents
,
follow-up visit
,
health evaluation
,
hemoglobin a, glycosylated
,
screening
Diabetes Care April 2022, Vol.45, 1346-1354. doi:https://doi.org/10.2337/dc21-1841
Trends and Demographic Disparities in Diabetes Hospital Admissions: Analyses of Serial Cross-Sectional National and State Data, 2008–2017
Sara D. Turbow; Tegveer S. Uppal; J. Sonya Haw; Puneet Chehal; Gail Fernandes; Megha Shah; Swapnil Rajpathak; Mohammed K. Ali; K.M. Venkat Narayan
Topics:
health disparity
,
hospital admission
,
kentucky
,
florida
,
nebraska
Diabetes Care April 2022, Vol.45, 1355-1363. doi:https://doi.org/10.2337/dc21-1837
Association Between Diabetes and Gray Matter Atrophy Patterns in a General Older Japanese Population: The Hisayama Study
Naoki Hirabayashi; Jun Hata; Yoshihiko Furuta; Tomoyuki Ohara; Mao Shibata; Yoichiro Hirakawa; Fumio Yamashita; Kazufumi Yoshihara; Takanari Kitazono; Nobuyuki Sudo; Toshiharu Ninomiya
Topics:
atrophy
,
gray matter
,
dementia
,
brain mri
,
brain
Diabetes Care May 2022, Vol.45, 1364-1371. doi:https://doi.org/10.2337/dc21-1911
Emerging Therapies: Drugs and Regimens
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose
Mariam Alatrach; Christina Agyin; Carolina Solis-Herrera; Olga Lavryneko; John Adams; Amalia Gastaldelli; Curtis Triplitt; Ralph A. DeFronzo; Eugenio Cersosimo
Topics:
diabetes mellitus, type 2
,
glucose
,
insulin
,
dapagliflozin
,
glucagon
Diabetes Care March 2022, Vol.45, 1372-1380. doi:https://doi.org/10.2337/dc21-1798
Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge
Topics:
child
,
fasting
,
glucose
,
hypoglycemia
,
insulin
Diabetes Care April 2022, Vol.45, 1381-1390. doi:https://doi.org/10.2337/dc21-2009
Low-Dose Dasiglucagon Versus Oral Glucose for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes: A Phase 2, Randomized, Three-Arm Crossover Study
Topics:
dasiglucagon
,
diabetes mellitus, type 1
,
glucose
,
hypoglycemia
,
insulin
Diabetes Care April 2022, Vol.45, 1391-1399. doi:https://doi.org/10.2337/dc21-2304
Pathophysiology / Complications
Lack of Evidence for a Causal Role of Hyperinsulinemia in the Progression of Obesity in Children and Adolescents: A Longitudinal Study
Topics:
fasting
,
glucose
,
hyperinsulinism
,
insulin
,
obesity
Diabetes Care March 2022, Vol.45, 1400-1407. doi:https://doi.org/10.2337/dc21-2210
The SGLT2 Inhibitor Dapagliflozin Increases the Oxidation of Ingested Fatty Acids to Ketones in Type 2 Diabetes
Roselle A. Herring; Fariba Shojaee-Moradie; Mary Stevenage; Iain Parsons; Nicola Jackson; Jeewaka Mendis; Benita Middleton; A. Margot Umpleby; Barbara A. Fielding; Melanie Davies; David L. Russell-Jones
Topics:
dapagliflozin
,
diabetes mellitus, type 2
,
fatty acids
,
glucose
,
ketones
Diabetes Care March 2022, Vol.45, 1408-1415. doi:https://doi.org/10.2337/dc21-2043
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes
Christine P. Limonte; Erkka Valo; Viktor Drel; Loki Natarajan; Manjula Darshi; Carol Forsblom; Clark M. Henderson; Andrew N. Hoofnagle; Wenjun Ju; Matthias Kretzler; Daniel Montemayor; Viji Nair; Robert G. Nelson; John F. O’Toole; Robert D. Toto; Sylvia E. Rosas; John Ruzinski; Niina Sandholm; Insa M. Schmidt; Tomas Vaisar; Sushrut S. Waikar; Jing Zhang; Peter Rossing; Tarunveer S. Ahluwalia; Per-Henrik Groop; Subramaniam Pennathur; Janet K. Snell-Bergeon; Tina Costacou; Trevor J. Orchard; Kumar Sharma; Ian H. de Boer; for the Kidney Precision Medicine Project
Topics:
biological markers
,
cathepsin d
,
kidney
,
urine
,
proteomics
Diabetes Care April 2022, Vol.45, 1416-1427. doi:https://doi.org/10.2337/dc21-2204
An Atypical Form of Diabetes Among Individuals With Low BMI
Eric Lontchi-Yimagou; Riddhi Dasgupta; Shajith Anoop; Sylvia Kehlenbrink; Sudha Koppaka; Akankasha Goyal; Padmanaban Venkatesan; Roshan Livingstone; Kenny Ye; Aaron Chapla; Michelle Carey; Arun Jose; Grace Rebekah; Anneka Wickramanayake; Mini Joseph; Priyanka Mathias; Anjali Manavalan; Mathews Edatharayil Kurian; Mercy Inbakumari; Flory Christina; Daniel Stein; Nihal Thomas; Meredith Hawkins
Topics:
body mass index procedure
,
c-peptide
,
diabetes mellitus, type 2
,
glucose
,
insulin
Diabetes Care May 2022, Vol.45, 1428-1437. doi:https://doi.org/10.2337/dc21-1957
Cardiovascular and Metabolic Risk
Stress Hyperglycemia Is Associated With an Increased Risk of Subsequent Development of Diabetes Among Bacteremic and Nonbacteremic Patients
Xiansong Wang; Frankie T.F. Cheng; Thomas Y.T. Lam; Yingzhi Liu; Dan Huang; Xiaodong Liu; Huarong Chen; Lin Zhang; Yusuf Ali; Maggie H.T. Wang; Jun Yu; Tony Gin; Matthew T.V. Chan; William K.K. Wu; Sunny H. Wong
Topics:
hyperglycemia
,
stress
,
undiagnosed
Diabetes Care March 2022, Vol.45, 1438-1444. doi:https://doi.org/10.2337/dc21-1682
Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials
Katherine R. Tuttle; Adeera Levin; Masaomi Nangaku; Takashi Kadowaki; Rajiv Agarwal; Sibylle J. Hauske; Amelie Elsäßer; Ivana Ritter; Dominik Steubl; Christoph Wanner; David C. Wheeler
Topics:
diabetes mellitus, type 2
,
empagliflozin
,
kidney failure, chronic
,
hyperkalemia
,
edema
Diabetes Care April 2022, Vol.45, 1445-1452. doi:https://doi.org/10.2337/dc21-2034
Associations of Serum Carotenoids With Risk of Cardiovascular Mortality Among Individuals With Type 2 Diabetes: Results From NHANES
Zixin Qiu; Xue Chen; Tingting Geng; Zhenzhen Wan; Qi Lu; Lin Li; Kai Zhu; Xuena Zhang; Yujie Liu; Xiaoyu Lin; Liangkai Chen; Zhilei Shan; Liegang Liu; An Pan; Gang Liu
Topics:
cardiovascular diseases
,
carotenoids
,
diabetes mellitus, type 2
,
national health and nutrition examination survey
,
lycopene
Diabetes Care May 2022, Vol.45, 1453-1461. doi:https://doi.org/10.2337/dc21-2371
The Importance of Office Blood Pressure Measurement Frequency and Methodology in Evaluating the Prevalence of Hypertension in Children and Adolescents With Type 1 Diabetes: The SWEET International Database
Andriani Vazeou; Sascha R. Tittel; Niels H. Birkebaek; Olga Kordonouri; Violeta Iotova; Barbara Piccini; Banshi Saboo; Auste Pundziute Lyckå; Sebastian Seget; David M. Maahs; George Stergiou
Topics:
blood pressure determination
,
hypertension
Diabetes Care April 2022, Vol.45, 1462-1471. doi:https://doi.org/10.2337/dc21-2472
Novel Communications in Diabetes
Retinal Capillary Damage Is Already Evident in Patients With Hypertension and Prediabetes and Associated With HbA1c Levels in the Nondiabetic Range
Dennis Kannenkeril; Janis M. Nolde; Márcio Galindo Kiuchi; Revathy Carnagarin; Leslie Marisol Lugo-Gavidia; Justine Chan; Anu Joyson; Ancy Jose; Sandi Robinson; Vance B. Matthews; Lakshini Y. Herat; Omar Azzam; Shaun Frost; Markus P. Schlaich
Topics:
blood capillaries
,
hemoglobin a, glycosylated
,
hypertension
,
prediabetes
,
insulin resistance
Diabetes Care March 2022, Vol.45, 1472-1475. doi:https://doi.org/10.2337/dc21-1569
Dasiglucagon Effectively Mitigates Postbariatric Postprandial Hypoglycemia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Casper K. Nielsen; Caroline C. Øhrstrøm; Urd L. Kielgast; Dorte L. Hansen; Bolette Hartmann; Jens J. Holst; Asger Lund; Tina Vilsbøll; Filip K. Knop
Topics:
dasiglucagon
,
reactive hypoglycemia
,
hypoglycemia
,
hypoglycemic agents
,
glucagon
Diabetes Care March 2022, Vol.45, 1476-1481. doi:https://doi.org/10.2337/dc21-2252
Diabetes Incidence Among Hispanic/Latino Adults in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
Christina Cordero; Neil Schneiderman; Maria M. Llabre; Yanping Teng; Martha L. Daviglus; Catherine C. Cowie; Jianwen Cai; Gregory A. Talavera; Linda C. Gallo; Robert C. Kaplan; Elizabeth M. Cespedes Feliciano; Rebeca A. Espinoza Giacinto; Aida L. Giachello; Larissa Avilés-Santa
Topics:
body mass index procedure
,
community health services
,
follow-up
,
glycemic control
,
obesity
Diabetes Care May 2022, Vol.45, 1482-1485. doi:https://doi.org/10.2337/dc21-1543
Carbohydrate Tolerance Threshold for Unannounced Snacks in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System
Gianluca Tornese; Claudia Carletti; Manuela Giangreco; Daniela Nisticò; Elena Faleschini; Egidio Barbi
Topics:
adolescent
,
carbohydrates
,
child
,
diabetes mellitus, type 1
,
insulin
Diabetes Care May 2022, Vol.45, 1486-1488. doi:https://doi.org/10.2337/dc21-2643
Errata
Erratum. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews. Diabetes Care 2021;44:2790–2811
Jamie Hartmann-Boyce; Karen Rees; James C. Perring; Sven A. Kerneis; Elizabeth M. Morris; Clare Goyder; Afolarin A. Otunla; Olivia E. James; Nandana R. Syam; Samuel Seidu; Kamlesh Khunti
Topics:
covid-19
Diabetes Care March 2022, Vol.45, 1489. doi:https://doi.org/10.2337/dc22-er06
Erratum. Controversies Around the Measurement of Blood Ketones to Diagnose and Manage Diabetic Ketoacidosis. Diabetes Care 2022;45:267–272
Topics:
diabetic ketoacidosis
,
ketones
Diabetes Care March 2022, Vol.45, 1490. doi:https://doi.org/10.2337/dc22-er06a
Erratum. The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence. Diabetes Care 2021;44:1734–1743
Topics:
quality control
,
software
,
verification
Diabetes Care April 2022, Vol.45, 1491. doi:https://doi.org/10.2337/dc22-er06b
Issues and Events
Issues and Events
Topics:
diabetic foot ulcer
,
evidence-based practice
,
inertia
,
mental health personnel
,
podcasts
Diabetes Care May 2022, Vol.45, 1492. doi:https://doi.org/10.2337/dc22-ie06
e-Letters
Observations
Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk
I-Wen Wu; Tsung-Hsien Tsai; Chi-Jen Lo; Yi-Ju Chou; Chi-Hsiao Yeh; Mei-Ling Cheng; Chi-Chun Lai; Huey-Kang Sytwu; Ting-Fen Tsai
Topics:
biological markers
,
diabetic nephropathy
,
citrulline
,
metabolites
,
n,n-dimethylarginine
Diabetes Care May 2022, Vol.45, e102-e104. doi:https://doi.org/10.2337/dc22-0145
Incidence of New-Onset Type 2 Diabetes After Cancer: A Danish Cohort Study
Lykke Sylow; Mia K. Grand; Annika von Heymann; Frederik Persson; Volkert Siersma; Margit Kriegbaum; Christen Lykkegaard Andersen; Christoffer Johansen
Topics:
cancer
,
diabetes mellitus, type 2
Diabetes Care May 2022, Vol.45, e105-e106. doi:https://doi.org/10.2337/dc22-0232
Trends in All-Cause and Cause-Specific Mortality Among Individuals With Diabetes Before and During the COVID-19 Pandemic in the U.S.
Donghee Kim; Omar Alshuwaykh; Keeryth K. Sandhu; Brittany B. Dennis; George Cholankeril; Aijaz Ahmed
Topics:
cardiovascular diseases
,
coronavirus pandemic
,
covid-19
,
cancer
,
kidney diseases
Diabetes Care April 2022, Vol.45, e107-e109. doi:https://doi.org/10.2337/dc22-0348
Comments and Responses
Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Topics:
diabetes mellitus, type 2
,
glycosylation end products, advanced
,
kidney failure, chronic
,
renal function
Diabetes Care May 2022, Vol.45, e110. doi:https://doi.org/10.2337/dc22-0337
Response to Comment on Koska et al. Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes. Diabetes Care 2022;44:684–691
Topics:
diabetes mellitus, type 2
,
glycosylation end products, advanced
,
kidney failure, chronic
,
renal function
Diabetes Care May 2022, Vol.45, e111-e112. doi:https://doi.org/10.2337/dci22-0013
